Beneficial ownership — 13D / 13G
87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | DSAQ Direct Selling Acquisition Corp. | 13G | 5.31% | Dec 31, 2023 | 2y |
| Brian Hirsch | KPLT Katapult Holdings, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | APGE Apogee Therapeutics, Inc. | 13G | 5.3% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | HLIO Helios Technologies, Inc. | 13G/A | 9.42% | Dec 31, 2023 | 2y |
| Ian Jacobs | SERV Serve Robotics Inc. | 13G/A | 0.5% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | DHAI DIH Holdings US, Inc. Class A Common Stock | 13G/A | 5.7% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BLFY Blue Foundry Bancorp | 13G/A | 11% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | RENT Rent the Runway, Inc. | 13G | 6.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PAR Par Technology Corp | 13G/A | 18.1% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | CABA Cabaletta Bio, Inc. | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | GOVX GeoVax Labs, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | KIDS Orthopediatrics Corp | 13G/A | 14.21% | Dec 31, 2023 | 2y |
| Lytton, Laurence W. | RNG RingCentral, Inc. | 13G/A | 1.8% | Dec 31, 2023 | 2y |
| Sandia Investment Management LP | BHAC Focus Impact BH3 Acquisition Company Class A Common Stock | 13G/A | 1.81% | Dec 31, 2023 | 2y |
| MOORE CAPITAL MANAGEMENT, LP | GCTS GCT Semiconductor Holding, Inc. | 13G | 7.2% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | TRVI Trevi Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Andrew J. Schwab | SCPH scPharmaceuticals Inc. Common Stock | 13G/A | 3.3% | Dec 31, 2023 | 2y |
| Gregory S. Daily | IIIV i3 Verticals, Inc. | 13G/A | 24.4% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | IVCA Investcorp AI Acquisition Corp. Class A Ordinary Share | 13G/A | 13.77% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | IMGN Immunogen Inc | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | OAKU Oak Woods Acquisition Corp | 13G | 9.36% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | BE Bloom Energy Corp | 13G/A | 14.49% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | HIW Highwoods Properties, Inc. | 13G/A | 16.15% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | RENEF Cartesian Growth Corp II | 13G | 5.49% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | COSM Cosmos Health Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | OLMA Olema Oncology, Inc. | 13G/A | 4.49% | Dec 31, 2023 | 2y |
| ATW SPAC MANAGEMENT LLC | ECDA ECD Automotive Design, Inc. | 13G/A | 0.5% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | AUTL Autolus Therapeutics plc | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | CULL Cullman Bancorp, Inc. | 13G | 7.4% | Dec 31, 2023 | 2y |
| PAR Investment Partners, L.P. | TRIP TripAdvisor, Inc. | 13G/A | 3.7% | Dec 31, 2023 | 2y |
| Cummins Inc. | ATMU Atmus Filtration Technologies Inc. | 13G | 80.5% | Dec 31, 2023 | 2y |
| Verition Fund Management LLC | LRMR Larimar Therapeutics, Inc. | 13G | 6.4% | Dec 31, 2023 | 2y |
| LONE PINE CAPITAL LLC | RH Rh | 13G/A | 0% | Dec 31, 2023 | 2y |
| Magnuson William | BRZE Braze, Inc. | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| Fort Baker Capital Management LP | LOKM Live Oak Mobility Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fund 1 Investments, LLC | VRA Vera Bradley, Inc. | 13G/A | 5.72% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | IRON Disc Medicine, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | HHLA HH&L Acquisition Co. | 13G | 9.9% | Dec 31, 2023 | 2y |
| Sky Top Capital International Limited | SFWL SHENGFENG DEVELOPMENT Ltd | 13G | 7.1% | Dec 31, 2023 | 2y |
| EdgePoint Investment Group Inc. | TCX Tucows Inc | 13G/A | 19.3% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | TCOA Zalatoris Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | MPV Barings Participation Investors | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| Pamplona Capital Partners V, L.P. | SWIM Latham Group, Inc. | 13G/A | 45.2% | Dec 31, 2023 | 2y |
| Arthur T. Sands | NRIX Nurix Therapeutics, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| Soviero Asset Management, LP | PBPB Potbelly Corporation Common Stock | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| Pentwater Capital Management LP | ICVX Icosavax, Inc. Common Stock | 13G | 5.9% | Dec 31, 2023 | 2y |
| MAVERICK CAPITAL LTD | WVE Wave Life Sciences, Inc. | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| Schuurman Steven | ESTC Elastic N.V. | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | FIGS FIGS, Inc. | 13G | 5.9% | Dec 31, 2023 | 2y |
| Harvey Partners, LLC | GLDD Great Lakes Dredge & Dock CORP | 13G/A | 5.1% | Dec 31, 2023 | 2y |